Last reviewed · How we verify
Placebo for V110
A placebo control arm contains no active pharmaceutical ingredient and serves as a comparator in clinical trials.
A placebo control arm contains no active pharmaceutical ingredient and serves as a comparator in clinical trials. Used for Control arm in V110 clinical trial (indication for V110 unknown).
At a glance
| Generic name | Placebo for V110 |
|---|---|
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Biologic |
| Phase | Phase 3 |
Mechanism of action
Placebos are inert substances used in randomized controlled trials to establish the efficacy of an investigational drug by comparison. In this case, the placebo is being used as a control arm in a Phase 3 trial for V110, a vaccine candidate in development by Merck Sharp & Dohme LLC. The placebo allows researchers to distinguish genuine therapeutic effects from natural disease progression or psychological effects.
Approved indications
- Control arm in V110 clinical trial (indication for V110 unknown)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |